IL6 and neoplasm: IL-6 and IL-8 from chemoresistant CAFs enrich CSCs by creating niches, and IL-32 in CAFs binds integrin β3, activating p38 MAPK signaling, upregulating EMT markers, and promoting tumor invasion.